Intra-Cellular Therapies (ITCI) Institutional Ownership

$84.51 -1.13 (-1.32%)

(As of 10:31 AM ET)

Current Institutional Ownership Percentage: 92.33%
Number of Institutional Buyers (last 12 months): 179
Total Institutional Inflows (last 12 months): $1.05B

Number of Institutional Sellers (last 12 months): 113
Total Institutional Outflows (last 12 months): $391.20M

Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ITCI Institutional Buying and Selling by Quarter

Ad Wide Moat Research

Trump said you could learn something from this man

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

Intra-Cellular Therapies Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Arete Wealth Advisors LLC	25,067	$1.83M	0.2%	+22.0%	0.024%
11/16/2024	Geode Capital Management LLC	1,708,301	$125.03M	0.0%	+1.3%	1.611%
11/15/2024	M&T Bank Corp	6,163	$451K	0.0%	+36.3%	0.006%
11/15/2024	Barclays PLC	34,453	$2.52M	0.0%	+282.0%	0.032%
11/15/2024	Public Employees Retirement System of Ohio	90,529	$6.62M	0.0%	-2.0%	0.085%
11/15/2024	Y Intercept Hong Kong Ltd	13,651	$999K	0.1%	-82.0%	0.013%
Get the Latest News and Ratings for ITCI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intra-Cellular Therapies and its competitors with MarketBeat's FREE daily newsletter.
11/15/2024	MML Investors Services LLC	3,997	$292K	0.0%	-3.2%	0.004%
11/15/2024	Pier Capital LLC	65,560	$4.80M	0.7%	+1.6%	0.062%
11/15/2024	Orion Portfolio Solutions LLC	22,434	$1.64M	0.0%	-5.8%	0.021%
11/15/2024	Castleark Management LLC	51,880	$3.80M	0.2%	-3.5%	0.049%
11/15/2024	Wellington Management Group LLP	1,017,647	$74.46M	0.0%	-18.8%	0.960%
11/15/2024	State Street Corp	1,858,915	$136.02M	0.0%	+3.1%	1.753%
11/15/2024	Quarry LP	1,800	$132K	0.0%	+260.0%	0.002%
11/15/2024	Point72 Asset Management L.P.	119,862	$8.77M	0.0%	-78.4%	0.113%
11/15/2024	Parkman Healthcare Partners LLC	241,575	$17.68M	2.3%	+30.6%	0.228%
11/15/2024	Janus Henderson Group PLC	42,729	$3.13M	0.0%	+6.4%	0.040%
11/15/2024	HighTower Advisors LLC	3,829	$280K	0.0%	N/A	0.004%
11/15/2024	HighVista Strategies LLC	7,496	$548K	0.2%	-69.2%	0.007%
11/15/2024	Holocene Advisors LP	1,370,831	$100.30M	0.4%	-7.4%	1.293%
11/15/2024	Point72 Hong Kong Ltd	6,293	$460K	0.0%	-85.8%	0.006%
11/15/2024	Erste Asset Management GmbH	23,400	$1.72M	0.0%	N/A	0.022%
11/15/2024	True Wealth Design LLC	434	$32K	0.0%	N/A	0.000%
11/14/2024	Bellevue Group AG	2,485,627	$181.87M	2.9%	+0.6%	2.344%
11/14/2024	Wasatch Advisors LP	3,848,588	$281.60M	1.4%	+3.5%	3.630%
11/14/2024	Edgestream Partners L.P.	54,629	$4.00M	0.2%	N/A	0.052%
11/14/2024	PFM Health Sciences LP	77,387	$5.66M	0.3%	-54.6%	0.073%
11/14/2024	Point72 Europe London LLP	19,385	$1.42M	0.1%	-40.0%	0.018%
11/14/2024	Captrust Financial Advisors	8,050	$589K	0.0%	+47.0%	0.008%
11/14/2024	Vestal Point Capital LP	30,000	$2.20M	0.2%	N/A	0.028%
11/14/2024	Suvretta Capital Management LLC	1,439,026	$105.29M	3.4%	-8.1%	1.357%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	323,208	$23.65M	0.0%	+3.6%	0.305%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	22,522	$1.65M	0.0%	+13.2%	0.021%
11/14/2024	MetLife Investment Management LLC	6,488	$475K	0.0%	-1.9%	0.006%
11/13/2024	Glenmede Trust Co. NA	11,469	$839K	0.0%	-10.1%	0.011%
11/13/2024	Cynosure Group LLC	14,442	$1.06M	0.2%	+161.0%	0.014%
11/13/2024	BNP Paribas Financial Markets	24,923	$1.82M	0.0%	-49.9%	0.024%
11/13/2024	FMR LLC	11,121,652	$813.77M	0.0%	-1.0%	10.490%
11/13/2024	The Manufacturers Life Insurance Company	22,057	$1.61M	0.0%	+1.3%	0.021%
11/13/2024	Bank of Montreal Can	64,198	$4.71M	0.0%	-78.1%	0.061%
11/12/2024	Westfield Capital Management Co. LP	1,159,356	$84.83M	0.4%	+11.2%	1.094%
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW
11/12/2024	Algert Global LLC	45,350	$3.32M	0.1%	-31.6%	0.043%
11/12/2024	Cerity Partners LLC	44,107	$3.23M	0.0%	+62.9%	0.042%
11/12/2024	Eagle Asset Management Inc.	624,759	$45.71M	0.2%	+130.5%	0.589%
11/12/2024	HealthInvest Partners AB	84,578	$6.19M	2.9%	+136.0%	0.080%
11/12/2024	Charles Schwab Investment Management Inc.	904,909	$66.21M	0.0%	-1.8%	0.854%
11/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	454,538	$33.26M	0.1%	+31.9%	0.429%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	17,099	$1.25M	0.0%	N/A	0.016%
11/8/2024	Commerce Bank	6,643	$486K	0.0%	-2.0%	0.006%
11/8/2024	Avior Wealth Management LLC	4,473	$327K	0.0%	+3.0%	0.004%
11/8/2024	B. Metzler seel. Sohn & Co. Holding AG	33,291	$2.44M	0.0%	N/A	0.031%
11/8/2024	Phocas Financial Corp.	19,233	$1.41M	0.0%	-5.9%	0.018%
11/7/2024	Whalen Wealth Management Inc.	2,996	$219K	0.2%	N/A	0.003%
11/7/2024	First Turn Management LLC	254,800	$18.64M	3.0%	-26.6%	0.240%
11/7/2024	LMR Partners LLP	31,177	$2.28M	0.0%	+96.2%	0.029%
11/7/2024	Swiss National Bank	185,500	$13.57M	0.0%	+8.1%	0.175%
11/6/2024	Mutual of America Capital Management LLC	44,091	$3.23M	0.0%	-0.9%	0.042%
11/6/2024	Natixis Advisors LLC	24,583	$1.80M	0.0%	-22.4%	0.023%
11/6/2024	Simplify Asset Management Inc.	30,883	$2.26M	0.1%	+66.6%	0.029%
11/6/2024	CIBC Asset Management Inc	2,806	$205K	0.0%	N/A	0.003%
11/6/2024	KBC Group NV	2,864	$210K	0.0%	+17.3%	0.003%
11/6/2024	Oppenheimer Asset Management Inc.	38,850	$2.84M	0.0%	+9.5%	0.037%
11/6/2024	MQS Management LLC	3,672	$269K	0.2%	N/A	0.003%
11/5/2024	Victory Capital Management Inc.	63,742	$4.66M	0.0%	-6.5%	0.060%
11/5/2024	Aigen Investment Management LP	14,890	$1.09M	0.2%	+91.3%	0.014%
11/5/2024	Prime Capital Investment Advisors LLC	7,420	$543K	0.0%	-5.0%	0.007%
11/5/2024	Entropy Technologies LP	7,116	$521K	0.1%	N/A	0.007%
11/4/2024	Versor Investments LP	3,509	$257K	0.0%	N/A	0.003%
11/4/2024	Lisanti Capital Growth LLC	58,115	$4.25M	1.1%	-29.9%	0.055%
11/4/2024	State of New Jersey Common Pension Fund D	35,673	$2.61M	0.0%	+0.6%	0.034%
11/4/2024	TimesSquare Capital Management LLC	438,083	$32.06M	0.5%	+6.5%	0.413%
11/2/2024	Covestor Ltd	1,811	$133K	0.1%	+40.4%	0.002%
11/1/2024	Atria Investments Inc	5,137	$376K	0.0%	+41.1%	0.005%
11/1/2024	Assetmark Inc.	2,477	$181K	0.0%	+9.1%	0.002%
11/1/2024	Capital Performance Advisors LLP	1,012	$74K	0.0%	N/A	0.001%
11/1/2024	Quantum Private Wealth LLC	38,661	$2.83M	1.0%	+1.0%	0.037%
10/31/2024	Principal Financial Group Inc.	597,713	$43.74M	0.0%	+3.3%	0.566%
10/31/2024	M&G PLC	124,324	$9.08M	0.0%	N/A	0.118%
10/29/2024	Emerald Advisers LLC	441,296	$32.29M	1.3%	+12.4%	0.418%
10/29/2024	Harbor Capital Advisors Inc.	34,974	$2.56M	0.1%	+144.6%	0.033%
10/29/2024	Emerald Mutual Fund Advisers Trust	334,673	$24.49M	1.3%	+6.6%	0.317%
10/28/2024	Oak Ridge Investments LLC	11,391	$833K	0.1%	-3.8%	0.011%
10/28/2024	US Bancorp DE	7,951	$582K	0.0%	+3.3%	0.008%
10/25/2024	Pinnacle Associates Ltd.	176,124	$12.61M	0.2%	+3.0%	0.167%
10/25/2024	China Universal Asset Management Co. Ltd.	20,323	$1.49M	0.2%	+63.9%	0.019%
10/25/2024	abrdn plc	250,963	$18.36M	0.0%	+7.5%	0.238%
10/25/2024	Pallas Capital Advisors LLC	2,990	$226K	0.0%	-27.4%	0.003%
10/24/2024	Nisa Investment Advisors LLC	2,676	$196K	0.0%	-35.8%	0.003%
10/24/2024	DekaBank Deutsche Girozentrale	51,997	$3.80M	0.0%	-1.0%	0.049%
10/24/2024	Wealth Enhancement Advisory Services LLC	8,810	$645K	0.0%	+185.6%	0.008%
10/24/2024	PFG Investments LLC	3,309	$242K	0.0%	-62.9%	0.003%
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now!
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,822	$280K	0.0%	+21.3%	0.004%
10/23/2024	Assenagon Asset Management S.A.	232,933	$17.04M	0.0%	-32.1%	0.221%
10/23/2024	Moody Aldrich Partners LLC	91,104	$6.67M	1.2%	-8.0%	0.086%
10/23/2024	Hennion & Walsh Asset Management Inc.	14,942	$1.09M	0.1%	-9.5%	0.014%
10/22/2024	Lecap Asset Management Ltd.	6,815	$499K	0.1%	N/A	0.006%
10/21/2024	Cetera Trust Company N.A	2,520	$184K	0.1%	+24.8%	0.002%
10/19/2024	Allspring Global Investments Holdings LLC	1,855	$136K	0.0%	-97.3%	0.002%
10/18/2024	Raymond James & Associates	158,852	$11.62M	0.0%	+2.8%	0.150%
10/16/2024	nVerses Capital LLC	3,900	$285K	0.1%	N/A	0.004%
10/11/2024	Creative Planning	16,188	$1.18M	0.0%	-17.5%	0.015%

(Data available from 1/1/2016 forward)

ITCI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ITCI shares?: During the previous two years, 311 institutional investors and hedge funds held shares of Intra-Cellular Therapies. The most heavily invested institutionals were FMR LLC ($813.77M), Vanguard Group Inc. ($638.44M), BlackRock Inc. ($480.67M), Wasatch Advisors LP ($281.60M), Avoro Capital Advisors LLC ($205.47M), Bellevue Group AG ($181.87M), and State Street Corp ($136.02M).Learn more on ITCI's institutional investors.
What percentage of Intra-Cellular Therapies stock is owned by institutional investors?: 92.33% of Intra-Cellular Therapies stock is owned by institutional investors. Learn more on ITCI's institutional investor holdings.
Which institutional investors have been buying Intra-Cellular Therapies stock?: Of the 269 institutional investors that purchased Intra-Cellular Therapies stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($3M), JPMorgan Chase & Co. ($1.54M), Norges Bank ($1.20M), Clearbridge Investments LLC ($1.10M), Perceptive Advisors LLC ($1.01M), Avidity Partners Management LP ($801.10K), and Vanguard Group Inc. ($729.95K).

How much institutional buying is happening at Intra-Cellular Therapies?: Institutional investors have bought a total of 25,821,501 shares in the last 24 months. This purchase volume represents approximately $1.66B in transactions.
Which Intra-Cellular Therapies major shareholders have been selling company stock?: Of the 157 institutional investors that sold Intra-Cellular Therapies stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lord Abbett & CO. LLC ($2.07M), Wasatch Advisors LP ($1.43M), Avidity Partners Management LP ($989.60K), Wellington Management Group LLP ($672.64K), TimesSquare Capital Management LLC ($550.55K), Assenagon Asset Management S.A. ($531.04K), and Point72 Asset Management L.P. ($434.32K).
How much institutional selling is happening at Intra-Cellular Therapies?: Institutional investors have sold a total of 13,634,991 shares in the last 24 months. This volume of shares sold represents approximately $841.11M in transactions.

Related Companies

This page (NASDAQ:ITCI) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intra-Cellular Therapies (ITCI) Institutional Ownership

ITCI Institutional Buying and Selling by Quarter

Intra-Cellular Therapies Major Shareholders & Ownership History

ITCI Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intra-Cellular Therapies (ITCI) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Intra-Cellular Therapies (NASDAQ:ITCI)

ITCI Institutional Buying and Selling by Quarter

Intra-Cellular Therapies Major Shareholders & Ownership History

ITCI Institutional Ownership - Frequently Asked Questions

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools